FDA’s “Belt and Suspenders” Approach to Mifepristone Approval
Political pressure and wary regulators shaped FDA’s mifepristone approval in 2000.
Seeking Continuous Improvement to the Administrative Process
ACUS identifies best practices for agency guidance, adjudications, and responses to constituent service requests.
When Money Talks, Agencies Listen
Scholars discuss how wealthy interest groups influence agency rulemaking.
Defining Discrimination in Health Care
The future of gender-affirming care may turn on the definition of “sex discrimination” in the Affordable Care Act.
Harnessing Clean Energy for Grid Reliability
Shelley Welton discusses how a comprehensive regulatory strategy for electric grid reliability can facilitate a transition to clean energy.
Week in Review
President Biden restricts oil and gas leasing on U.S. coastlines, the Justice Department brings antitrust case against major landlords, and more…
Revisiting EPA’s Forever Chemical Strategy
EPA has made significant progress on PFAS regulation over the past three years, but more work remains.
Centering Children in Public Health Regulation
Scholar proposes an increased focus on children’s health in food, drug, and cosmetic regulation.
Regulating Web 3.0 for a Safer Digital Future
Scholar argues that Web 3.0 technologies require federal regulatory guardrails.